{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:47:52Z","timestamp":1792180072747,"version":"4.4.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003481","name":"Hebei Normal University","doi-asserted-by":"publisher","award":["L2024ZD16"],"award-info":[{"award-number":["L2024ZD16"]}],"id":[{"id":"10.13039\/501100003481","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003481","name":"Hebei Normal University","doi-asserted-by":"publisher","award":["L2024J04"],"award-info":[{"award-number":["L2024J04"]}],"id":[{"id":"10.13039\/501100003481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115557","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:11:02Z","timestamp":1758600662000},"page":"115557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Identification of ferroptosis-related genes as diagnostic biomarkers and therapeutic targets in sorafenib-resistant HCC via machine learning and experimental validation"],"prefix":"10.1016","volume":"166","author":[{"given":"Jinrui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2025.115557_bb0005","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115557_bb0010","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.intimp.2025.115557_bb0015","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.intimp.2025.115557_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.801981","article-title":"Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review","volume":"10","author":"Zou","year":"2022","journal-title":"Front. Public Health"},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0025","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1186\/s12889-022-12867-w","article-title":"Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990-2019: a longitudinal analysis based on the global burden of disease study","volume":"22","author":"Amini","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.intimp.2025.115557_bb0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"issue":"4","key":"10.1016\/j.intimp.2025.115557_bb0035","first-page":"386","article-title":"Molecular pathogenesis and systemic therapies for hepatocellular carcinoma","volume":"3","author":"Llovet","year":"2022","journal-title":"Nat. Can."},{"issue":"4","key":"10.1016\/j.intimp.2025.115557_bb0040","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115557_bb0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000529824","article-title":"Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials","volume":"12","author":"Tan","year":"2023","journal-title":"Liver cancer"},{"issue":"15","key":"10.1016\/j.intimp.2025.115557_bb0050","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.4161\/cc.21193","article-title":"Molecular mechanisms of sorafenib action in liver cancer cells","volume":"11","author":"Cervello","year":"2012","journal-title":"Cell cycle (Georgetown, Tex.)"},{"issue":"19","key":"10.1016\/j.intimp.2025.115557_bb0055","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.115557_bb0060","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jhep.2011.01.047","article-title":"Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma","volume":"55","author":"Tai","year":"2011","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115557_bb0065","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/cancers12061576","article-title":"Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity","volume":"12","author":"Cabral","year":"2020","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.intimp.2025.115557_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102434","article-title":"Mechanisms of sorafenib resistance in hepatocellular carcinoma","volume":"48","author":"Liang","year":"2024","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2025.115557_bb0080","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.intimp.2025.115557_bb0085","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115557_bb0090","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115557_bb0095","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"14","key":"10.1016\/j.intimp.2025.115557_bb0100","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"6724","key":"10.1016\/j.intimp.2025.115557_bb0105","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.adn7030","article-title":"Ferroptosis-disease perils and therapeutic promise","volume":"vol. 386","author":"Brown","year":"2024","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.intimp.2025.115557_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188890","article-title":"GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2025.115557_bb0115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41419-023-05930-w","article-title":"Ferroptosis as a potential target for cancer therapy","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.intimp.2025.115557_bb0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2025.115557_bb0130","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.28574","article-title":"Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis","volume":"64","author":"Sun","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"7","key":"10.1016\/j.intimp.2025.115557_bb0135","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.28159","article-title":"Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib","volume":"133","author":"Louandre","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2025.115557_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101052","article-title":"Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma","volume":"73","author":"Hao","year":"2024","journal-title":"Drug Resist. Update."},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41419-023-05558-w","article-title":"SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase","volume":"14","author":"Xu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.intimp.2025.115557_bb0150","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/bph.15364","article-title":"Nuciferine protects against folic acid-induced acute kidney injury by inhibiting ferroptosis","volume":"178","author":"Li","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115557_bb0155","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/1878-0261.12936","article-title":"Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis","volume":"15","author":"Liu","year":"2021","journal-title":"Mol. Oncol."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2025.115557_bb0160","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s10495-024-01945-6","article-title":"A novel mitochondrial unfolded protein response-related risk signature to predict prognosis, immunotherapy and sorafenib sensitivity in hepatocellular carcinoma","volume":"29","author":"Zhang","year":"2024","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.intimp.2025.115557_bb0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.115557_bb0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ceb.2016.02.010","article-title":"Structure and function of the ULK1 complex in autophagy","volume":"39","author":"Lin","year":"2016","journal-title":"Curr. Opin. Cell Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115557_bb0175","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.tibs.2024.03.004","article-title":"ULK\/Atg1: phasing in and out of autophagy","volume":"49","author":"Wang","year":"2024","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2025.115557_bb0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ceb.2009.12.004","article-title":"The role of the Atg1\/ULK1 complex in autophagy regulation","volume":"22","author":"Mizushima","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115557_bb0185","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4161\/auto.7.6.15123","article-title":"The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR","volume":"7","author":"Egan","year":"2011","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.intimp.2025.115557_bb0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2025.115557_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116273","article-title":"The mechanism of UNC-51-like kinase 1 and the applications of small molecule modulators in cancer treatment","volume":"268","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2025.115557_bb0200","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1080\/15548627.2019.1709762","article-title":"The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target","volume":"16","author":"Xue","year":"2020","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0205","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12931-024-03076-7","article-title":"Ferritinophagy mediated by the AMPK\/ULK1 pathway is involved in ferroptosis subsequent to ventilator-induced lung injury","volume":"25","author":"Ou","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2025.115557_bb0210","first-page":"0860","article-title":"AMPK-ULK1-Mediated Ferritinophagy Drives Ferroptosis in GLA-Induced Testicular Toxicity","volume":"8","author":"Wang","year":"2025","journal-title":"Research (Washington, D.C.)"},{"key":"10.1016\/j.intimp.2025.115557_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146772","article-title":"Function and regulation of ULK1: From physiology to pathology","volume":"840","author":"Rong","year":"2022","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.intimp.2025.115557_bb0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molcel.2015.05.031","article-title":"Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates","volume":"59","author":"Egan","year":"2015","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.intimp.2025.115557_bb0225","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/ijms24020953","article-title":"Small Molecule Inhibitors for Unc-51-like Autophagy-Activating Kinase Targeting Autophagy in Cancer","volume":"24","author":"Karmacharya","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.intimp.2025.115557_bb0230","doi-asserted-by":"crossref","first-page":"14609","DOI":"10.1021\/acs.jmedchem.0c00873","article-title":"Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1\/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer","volume":"63","author":"Ren","year":"2020","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2025.115557_bb0235","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41419-020-02885-0","article-title":"Dual targeting of NUAK1 and ULK1 using the multitargeted inhibitor MRT68921 exerts potent antitumor activities","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0240","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13046-020-01580-4","article-title":"ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia","volume":"39","author":"Hwang","year":"2020","journal-title":"J Exp. Clin. Canc. Res."},{"issue":"15","key":"10.1016\/j.intimp.2025.115557_bb0245","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.ejca.2011.07.008","article-title":"Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours","volume":"47","author":"Sch\u00f6ffski","year":"2011","journal-title":"European journal of cancer (Oxford, England\u202f: 1990)"},{"key":"10.1016\/j.intimp.2025.115557_bb0250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.isci.2018.09.012","article-title":"A Potent and Selective ULK1 Inhibitor Suppresses Autophagy and Sensitizes Cancer Cells to Nutrient Stress","volume":"8","author":"Martin","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.intimp.2025.115557_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117260","article-title":"Substituted indole derivatives as UNC-51-like kinase 1 inhibitors: Design, synthesis and anti-hepatocellular carcinoma activity","volume":"178","author":"Zhao","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.intimp.2025.115557_bb0260","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.3892\/or.2017.5635","article-title":"SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways","volume":"37","author":"Tang","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2025.115557_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117234","article-title":"Targeted inhibition of ULK1 enhances daunorubicin sensitivity in acute myeloid leukemia","volume":"243","author":"Qiu","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0270","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12885-021-07901-w","article-title":"Blockage of AMPK-ULK1 pathway mediated autophagy promotes cell apoptosis to increase doxorubicin sensitivity in breast cancer (BC) cells: an in vitro study","volume":"21","author":"Yu","year":"2021","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2025.115557_bb0275","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/BJ20121753","article-title":"Physiological and pathological roles of mitochondrial SLC25 carriers","volume":"454","author":"Guti\u00e9rrez-Aguilar","year":"2013","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.intimp.2025.115557_bb0280","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/MCB.01685-08","article-title":"Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2","volume":"29","author":"Paradkar","year":"2009","journal-title":"Mol. Cell. Biol."},{"issue":"7080","key":"10.1016\/j.intimp.2025.115557_bb0285","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature04512","article-title":"Mitoferrin is essential for erythroid iron assimilation","volume":"440","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115557_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101619","article-title":"The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells","volume":"36","author":"Zhang","year":"2020","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115557_bb0295","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41418-022-00943-y","article-title":"p53 in ferroptosis regulation: the new weapon for the old guardian","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.intimp.2025.115557_bb0300","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","article-title":"Connecting copper and cancer: from transition metal signalling to metalloplasia","volume":"22","author":"Ge","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2025.115557_bb0305","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1039\/C6MT00202A","article-title":"Defining the human copper proteome and analysis of its expression variation in cancers","volume":"9","author":"Blockhuys","year":"2017","journal-title":"Metallomics"},{"issue":"6586","key":"10.1016\/j.intimp.2025.115557_bb0310","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0315","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12935-025-03683-4","article-title":"Cuproplasia and cuproptosis in hepatocellular carcinoma: mechanisms, relationship and potential role in tumor microenvironment and treatment","volume":"25","author":"Zhang","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.intimp.2025.115557_bb0320","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","article-title":"Cuproptosis: a copper-triggered modality of mitochondrial cell death","volume":"32","author":"Tang","year":"2022","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0325","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s11658-024-00608-3","article-title":"Cuproptosis in cancer: biological implications and therapeutic opportunities","volume":"29","author":"Li","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.intimp.2025.115557_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101018","article-title":"Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance","volume":"72","author":"Wang","year":"2024","journal-title":"Drug Resis. Update."},{"issue":"3","key":"10.1016\/j.intimp.2025.115557_bb0335","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41401-022-00981-9","article-title":"Sorafenib triggers ferroptosis via inhibition of HBXIP\/SCD axis in hepatocellular carcinoma","volume":"44","author":"Zhang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0340","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","article-title":"Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer","volume":"42","author":"Wang","year":"2023","journal-title":"J Exp. Clin. Canc. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0345","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s13023-025-03959-y","article-title":"ECHS1: pathogenic mechanisms, experimental models, and emerging therapeutic strategies","volume":"20","author":"Fu","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.intimp.2025.115557_bb0350","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.biopha.2011.02.010","article-title":"Enoyl coenzyme A hydratase 1 is an important factor in the lymphatic metastasis of tumors","volume":"65","author":"Zhang","year":"2011","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0355","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41467-017-00489-5","article-title":"Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2025.115557_bb0360","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbrc.2018.03.052","article-title":"Enoyl coenzyme A hydratase 1 protects against high-fat-diet-induced hepatic steatosis and insulin resistance","volume":"499","author":"Huang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2025.115557_bb0365","doi-asserted-by":"crossref","first-page":"418","DOI":"10.7150\/jca.88604","article-title":"Expression and clinical significance of ECHS1 in gastric cancer","volume":"15","author":"Lu","year":"2024","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2025.115557_bb0370","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cell.2024.10.047","article-title":"ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.intimp.2025.115557_bb0375","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.biopha.2013.03.018","article-title":"Ech1 is a potent suppressor of lymphatic metastasis in hepatocarcinoma","volume":"67","author":"Zhang","year":"2013","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"3","key":"10.1016\/j.intimp.2025.115557_bb0380","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1615\/CritRevEukaryotGeneExpr.2013007531","article-title":"Knockdown of ECHS1 protein expression inhibits hepatocellular carcinoma cell proliferation via suppression of Akt activity","volume":"23","author":"Zhu","year":"2013","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"1","key":"10.1016\/j.intimp.2025.115557_bb0385","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2012.11.030","article-title":"ECHS1 acts as a novel HBsAg-binding protein enhancing apoptosis through the mitochondrial pathway in HepG2 cells","volume":"330","author":"Xiao","year":"2013","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.intimp.2025.115557_bb0390","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4149\/neo_2015_106","article-title":"Silencing ECHS1 attenuates the proliferation and induces the autophagy of hepatocellular carcinoma via impairing cell metabolism and activating AMPK","volume":"62","author":"Xu","year":"2015","journal-title":"Neoplasma"},{"issue":"5","key":"10.1016\/j.intimp.2025.115557_bb0395","first-page":"1357","article-title":"Genetic alterations in doxorubicin-resistant hepatocellular carcinoma cells: a combined study of spectral karyotyping, positional expression profiling and candidate genes","volume":"25","author":"Hu","year":"2004","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115557_bb0400","first-page":"E925","article-title":"Enoyl coenzyme A hydratase 1 alleviates nonalcoholic steatohepatitis in mice by suppressing hepatic ferroptosis, American journal of physiology","volume":"320","author":"Liu","year":"2021","journal-title":"Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.intimp.2025.115557_bb0405","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178550","article-title":"TRAF3 loss protects glioblastoma cells from lipid peroxidation and immune elimination via dysregulated lipid metabolism","volume":"135","author":"Zeng","year":"2025","journal-title":"J. Clin. Invest."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925015486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925015486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T03:57:31Z","timestamp":1763697451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925015486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":81,"alternative-id":["S1567576925015486"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115557","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of ferroptosis-related genes as diagnostic biomarkers and therapeutic targets in sorafenib-resistant HCC via machine learning and experimental validation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115557"}}